Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic Insights
- 6 May 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (10) , 11844-11871
Abstract
Inhibitors of the 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR), an enzyme of the nonmevalonate pathway, represent a promising class of antiplasmodial compounds, as DXR is essential for human pathogens but absent in their host. The natural product fosmidomycin was the first clinical DXR inhibitor, however high rates of recrudescence attributed to the polar phosphonic acid group have prevented progression beyond phase II clinical trials. Herein, lipophilic N-benzamidoalkyl and N-phthalimidoalkyl substituents were introduced into reverse α-phenyl fosmidomycin derivatives to mimic the nicotinamide moiety of the NADPH cofactor and enhance antiplasmodial activity. Elongation of the alkyl linker markedly improved enzymatic inhibition (15e PfDXR IC50 = 4.3 nM) and antiplasmodial activity (16e PfDd2 IC50 = 0.28 μM). Mode of inhibition studies showed competitive inhibition with the DXR substrate and the cofactor NADPH (16e Ki = 0.068 μM). Co-crystallization with the PfDXR enzyme revealed that the introduced residues bind within the NADPH binding site.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst (91705741)
- Deutscher Akademischer Austauschdienst (PPP 57609844)
- Deutsche Forschungsgemeinschaft (270650915/GRK 2158)
- Ministry of Higher Education and Scientific Research
- Japan Society for the Promotion of Science
- Heiwa Nakajima Foundation
This publication has 64 references indexed in Scilit:
- Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agentsEuropean Journal of Medicinal Chemistry, 2022
- The blood-to-plasma ratio and predicted GABAA-binding affinity of designer benzodiazepinesForensic Toxicology, 2022
- Decision trees to characterise the roles of permeability and solubility on the prediction of oral absorptionEuropean Journal of Medicinal Chemistry, 2015
- Synthesis and Antiplasmodial Activity of Highly Active Reverse Analogues of the Antimalarial Drug Candidate FosmidomycinChemMedChem, 2010
- Biosynthesis of isoprenoids via the non-mevalonate pathwayCellular and Molecular Life Sciences, 2004
- Fosmidomycin for the treatment of malariaParasitology Research, 2003
- Structure validation by Cα geometry: ϕ,ψ and Cβ deviationProteins: Structure, Function, and Bioinformatics, 2003
- The Neutrophil NADPH OxidaseArchives of Biochemistry and Biophysics, 2002
- Program DYNAFIT for the Analysis of Enzyme Kinetic Data: Application to HIV ProteinaseAnalytical Biochemistry, 1996
- A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90)Journal of Tissue Culture Methods, 1985